secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2023-09-29T23:59:59+00:00
Accession:  0000950170-23-050819
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical receives Nasdaq delisting notice for bid price below $1.00
-------------------------------------------------------------------------------

- Received Nasdaq notice on Sept 27, 2023 for non-compliance with minimum bid price rule.
- Must regain compliance by March 25, 2024; bid price must close at $1.00+ for 10 consecutive days.
- May transfer to Nasdaq Capital Market or effect a reverse stock split to cure the deficiency.
- Failure to regain compliance could lead to delisting, impairing liquidity and capital access.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017023050819/0000950170-23-050819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017023050819/clsd-20230927.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-050819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer